Hypoxia-inducible factor-1 in human breast and prostate cancer.

Hypoxia-inducible factor-1 in human breast and prostate cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Hypoxia-inducible factor-1 in human breast and prostate cancer. Abstract Text:

K S Kimbro,J W Simons,

The tumor microenvironment is best characterized as a fluctuation of hypoxia and nutrient deprivation, which leads to epigenetic and genetic adaptation of clones and increased invasiveness and metastasis. In turn, these hypoxic adaptations make the tumors more difficult to treat and confer increased resistance to current therapies. Part of this adaptation is the regulation of gene products in response to hypoxia. Many of these hypoxia-regulated genes are mediated by the hypoxia-inducible factor 1 (HIF-1) complex, which is composed of a heterodimer pair of HIF-1alpha and HIF-1beta. This heterodimer binds to the promoter of hypoxia-responsive genes, while interacting with other transcription factors, such as p300, signal and transducer of transcription 3, and Redox effector factor 1/apurinic/apyrimidinic endonuclease. HIF-1alpha levels itself can be regulated by hypoxia transcriptionally and post-translationally through ubiquitination; but the magnitude of the response is modulated by several other pathways, including free radicals that affect crosstalk with HIF-1alpha/HIF-1beta transcriptional activities. HIF-1alpha has emerged as an important transcription factor in breast cancer and prostate cancer biology, and is expressed in the early stages of mammary and prostate carcinogenesis. Its expression is correlated with diagnostic and prognostic indicators for early relapse and metastatic disease, thus making HIF-1alpha a potential prognostic biomarker in proteomic assessments of breast and prostate cancers. The importance of HIF-1alpha in tumor progression makes it a logical target for chemoprevention strategies in patients at higher genetic risk of breast and prostate cancer with Cox 2 inhibitors or 2-methoxyestradiol, as well as a target for new approaches to inhibiting angiogenesis. The crosstalk between estrogen signaling pathways and HIF-1alpha is still not fully defined in breast cancer, but downstream estrogen receptor signaling may be a candidate for estrogen modulation of HIF-1alpha levels. In prostate cancer, androgens upregulate HIF-1alpha through androgen-regulated autocrine receptor tyrosine kinase receptor signaling. This review will put into perspective the role of HIF-1alpha in endocrine oncology and present new data on HIF-1alpha signaling and the potential for targeted therapies, including combinatory hormonal therapies.

Hypoxia-inducible factor-1 in human breast and prostate cancer. Publishing Authors By Initials

KS Kimbro,JW Simons,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Hypoxia-inducible factor-1 in human breast and prostate cancer. Journal Published:

PUBLICATION TYPE: Review

Journal: Endocrine-related cancer

VOLUME: 13

Page Numbers: 739-49

Journal Abbreviation:

ISSN: 1351-0088

DAY: 3

MONTH: Sep

YEAR: 2006

Hypoxia-inducible factor-1 in human breast and prostate cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9436481

Hypoxia-inducible factor-1 in human breast and prostate cancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Hypoxia-inducible factor-1 in human breast and prostate cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Hypoxia-inducible factor-1 in human breast and prostate cancer.

AFFILIATION: Department of Hematology and Oncology, Emory School of Medicine, Winship Cancer Institute, 1365 Clifton Road, NE, Atlanta, Georgia 30322, USA. sean.kimbro@emorythealthcare.org

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Endocr Relat Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Hypoxia-inducible factor-1 in human breast and prostate cancer Related Publications

• (1)H NMR spectral simplification with achiral and chiral lanthanide shift reagents - IV. Thiopental and barbiturate analogues.
• 333.
• Active internal re-warming using a centrifugal pump and heat exchanger following haemorrhagic shock, surgical trauma and hypothermia in a porcine model.
• Adaptation of trigeminal ganglion cells to periodic whisker deflections.
• Affective differences among daily tobacco users, occasional users, and non-users.
• Angularly nonspecific response suppression in rat barrel cortex.
• Antiangiogenic plasma activity in patients with systemic sclerosis.
• Attending to affect: appraisal strategies modulate the electrocortical response to arousing pictures.
• Buprenorphine and methadone: a comparison of patient completion rates during inpatient detoxification.
• Designing medication safety in the NICU.
• Detergent resistance as a tool in membrane research.
• Discovery of the smallest Fayum Egyptian primates (Anchomomyini, Adapidae).
• Hypoxia-inducible factor-1 in human breast and prostate cancer.
• Inference in regression models of heavily skewed alcohol use data: A comparison of ordinary least squares, generalized linear models, and bootstrap resampling.
• It's worse than you thought: the feedback negativity and violations of reward prediction in gambling tasks.
• Kinetics of cell division in epidermal maintenance.
• Layer- and cell-type-specific effects of neonatal whisker-trimming in adult rat barrel cortex.
• Molecular characterization of defective antigen processing in human prostate cancer.
• Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice.
• Nanotechnology applications in cancer.
• Patency of endovascular treatment for central venous stenosis: is there a difference between dialysis fistulas and grafts?
• Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.
• Private lives and public programs: an Australian longitudinal study of the elderly.
• Prospective teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and loss of CYP26 activity.
• Pubertal maturation and early substance use risks among African American children.
• Resolution of a heart abnormality? - basketball: 1126: june 1 4:15 PM - 4:35 PM.
• Sequential chemotactic and phagocytic activation of human polymorphonuclear neutrophils.
• Silky, sticky chimeras-designer VEGFs display their wares.
• The extracellular matrix and blood vessel formation: not just a scaffold.
• Wearable Wireless Telemetry System for Implantable Bio-MEMS Sensors.